259 results on '"Lo, S.S."'
Search Results
2. SBRT for Metastatic Disease to the Sacrum
3. Dosimetric Impact of Radiolucent Carbon Fiber Hardware for Post-Operative Spine Stereotactic Body Radiation Therapy
4. Multi-Institutional Validation of the Recursive Partitioning Analysis for Overall Survival in Patients Undergoing Spine Radiosurgery for Spine Metastasis
5. Craniospinal Irradiation for CNS Leukemia: Rates of Response and Durability of CNS Control
6. 5-Year Renal Function Outcomes after SABR for Primary Renal Cell Carcinoma: A Report from the International Radiosurgery Oncology Consortium of the Kidney (IROCK)
7. Clinical Outcomes Following Stereotactic Body Radiation Therapy (SBRT) for Non-Spinal Bone Metastases: A Systematic Review and Meta-Analysis
8. Dual Immune Checkpoint Blockade and Hypofractionated Radiation in Recurrent/Metastatic Squamous Cell Carcinomas of the Head and Neck Previously Treated with Immune Checkpoint Inhibitors
9. Long-Term Outcomes of SABR to Primary Renal Cell Carcinoma: A Multicenter Analysis from IROCK (International Radiosurgery Oncology Consortium for Kidney)
10. Multi-Institutional Datasets Validate the Recursive Partitioning Analysis for Overall Survival in Patients Undergoing Spine Radiosurgery for Spine Metastasis
11. Serious Complications Associated with Stereotactic Ablative Radiotherapy and Strategies to Mitigate the Risk
12. International Practice Survey on the Management of Brain Metastases: Third International Consensus Workshop on Palliative Radiotherapy and Symptom Control
13. The Role of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic and Oligoprogressive Gynecologic Malignancies: A Multi-Institutional Pooled Analysis
14. Prognostic Impact of Biologically Equivalent Dose in Stereotactic Body Radiation Therapy for Renal Cancer
15. International Consensus Contouring Recommendations for Stereotactic Body Radiotherapy of Non-Spine Bone Metastases
16. Is the Promise of Diffusion-weighed (DWI) MRI based Therapy Response Prediction in Advanced Cervical Cancer Ready for Prime Time in Standard Community Settings? The Issue of Standardized Postprocessing
17. Stage migration influences on stage-specific survival comparison between D1 and D3 gastric cancer surgeries
18. A Multi-Institutional Retrospective Clinical and Dosimetric Analyses of 1033 Oligometastatic Patients Treated with SBRT from the Consortium for Oligometastases Research - CORE
19. Stereotactic Body Radiotherapy for Non-Spine Bone Metastases: An International Survey of Practice Patterns
20. Stereotactic Body Radiotherapy for Large Primary Renal Cell Carcinoma: A Report from the International Radiosurgery Oncology Consortium for Kidney (IROCK)
21. Hypofractionated Stereotactic Radiotherapy to the Resection Cavity in Patients with Brain Metastases: An International Multi-Institutional Analysis of Prognostic Factors and Outcomes
22. Consensus Guidelines for Target Volume Definition of the Sacrum in Spinal Stereotactic Body Radiation Therapy (SBRT)
23. DNA Repair Deficiency, Genomic Instability and Immune Profiling in a Phase 1 Study of Locally Advanced Pancreatic Cancer Patients Treated with Veliparib, Gemcitabine and Radiation Therapy
24. Dose Escalation to 60 Gy in 3 Fractions with Stereotactic Body Radiation Therapy (SBRT) for Poor Surgical Candidates with Localized Renal Cell Carcinoma: Expansion of a Phase I Study
25. Nodular Leptomeningeal Disease – A Distinct Pattern of Recurrence after Post-Resection Stereotactic Radiosurgery for Brain Metastases: A Multi-Institutional Study of Inter-Observer Reliability
26. Renal SABR in Patients with a Solitary Kidney: An Individual-Patient Pooled Analysis from the International Radiosurgery Oncology Consortium for Kidney (IROCK)
27. Curative Intent Radiation Therapy Delivered Within the Last Year of Life
28. An International Radiosurgery Consortium Survey for Gynecological Stereotactic Ablative Radiation Therapy
29. Hypofractionated Stereotactic Radiation Therapy to the Surgical Bed for Patients With Brain Metastases Provides Effective Local Control for Bed ≥ 48
30. Use of Radiation Within the Last Year of Life Among Cancer Patients
31. Individual Patient Data Meta-analysis of SBRT Kidney: A Report From the International Radiosurgery Oncology Consortium for Kidney (IROCK)
32. EP-1414: Toxicity of concurrent stereotactic radiotherapy and targeted or immunotherapy: a systematic review
33. Consensus Statement From the International Stereotactic Body Radiotherapy Consortium for Head and Neck Carcinoma—Technical Factors
34. Outcomes and Toxicities in Patients Treated With Definitive Focal Therapy for Primary Prostate Cancer: A Systematic Review
35. Consensus Statement From the International Stereotactic Body Radiotherapy Consortium for Head and Neck Carcinoma—Patient Selection and Pre- and Post-Stereotactic Body Radiation Therapy Evaluation
36. Stereotactic Body Radiation Therapy for Low-Intermediate Risk Prostate Cancer—A Single-Institution Initial Analysis of Toxicity
37. An Independently Validated Nomogram for Individualized Estimation of Survival Among Patients With Newly Diagnosed Glioblastoma: NRG Oncology/RTOG 0525 and 0825
38. A Multinational Report on Factors of Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma: Patient Selection and Follow-up
39. International Consensus Contouring Guidelines for Postoperative Spine Stereotactic Body Radiation Therapy (SBRT)
40. A Multinational Report on Technical Factors of Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma
41. Consensus Guidelines Postoperative Stereotactic Body Radiation Therapy (SBRT) for Malignant Spinal Tumors: Results of an International Survey
42. Concurrent Carboplatin and Gemcitabine With SBRT for Persistent or Recurrent Gynecological Cancers: A Phase 1 Trial
43. A Multi-National Report on Technical Factors of Stereotactic Body Radiation Therapy for Oligometastases
44. A Multinational Report on Image-Guided Stereotactic Body Radiation Therapy for Oligometastases: Patient Selection and Follow-Up
45. Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer: Relationship Between Biological Equivalent Dose Based on the Generalized LQ Model and Local Control
46. Patient-Specific TCP Based on the gLQ Model–A Strong Outcome Predictor in Radiation Therapy for Cervical Cancer
47. Topology of DCE MR Perfusion Pattern Within Cervical Cancers During Radiation Therapy
48. Is Cellular Radiosensitivity Influenced by Tumor Perfusion Status During Radiation Therapy of Cervical Cancer?
49. Structural Properties and Surface Plasmon Polariton Propagation of Gold Nanoplates
50. Reirradiation With Stereotactic Body Radiation Therapy (SBRT): Analysis of Human Spinal Cord Tolerance Using the Generalized Linear-quadratic Model
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.